Skip to main content
Case Study Graduate 1,916 words

Bipolar Disorder Therapy: Three Clinical Decisions Explored

~10 min read
Abstract

This paper examines the clinical management of a 26-year-old Korean-American woman diagnosed with bipolar disorder following a three-week hospitalization for acute mania. Drawing on a case-based framework, the paper presents three sequential treatment decisions: reinforcing adherence to prescribed Lithium therapy, assessing and addressing the root causes of medication non-compliance, and evaluating the use of Seroquel XR 300 mg for symptom management. Each decision is analyzed in terms of its clinical rationale, expected outcomes, and ethical implications — with particular attention to cultural competency, patient autonomy, confidentiality, and the ethics of patient education. The paper highlights how pharmacogenomic factors such as the CYP2D6*10 allele influence treatment response and underscores the importance of culturally sensitive, patient-centered care in bipolar disorder management.

Key Takeaways
  • Introduction to the Case: Patient background, diagnosis, and presenting symptoms
  • Decision 1: Reinforcing Lithium Adherence: Rationale for continuing Lithium and ethical considerations
  • Decision 2: Assessing and Addressing Medication Non-Compliance: Exploring non-compliance causes and patient education ethics
  • Decision 3: Seroquel XR as a Treatment Option: Seroquel XR use, expected outcomes, and side effects
  • Conclusion: Summary of decisions and ethical obligations for practitioners
✍️ How to write this paper — guide, tools & examples

What makes this paper effective

  • The paper uses a structured, decision-based framework that mirrors real clinical reasoning, making it practical and easy to follow.
  • Each decision is supported by peer-reviewed citations, grounding clinical choices in evidence-based practice rather than opinion.
  • Ethical considerations are consistently integrated into each decision section, demonstrating that the author understands the intersection of clinical and professional responsibilities.
  • Attention to pharmacogenomics (CYP2D6*10 allele) shows nuanced understanding of individualized patient care.

Key academic technique demonstrated

The paper demonstrates clinical decision justification — for each option selected, the author explicitly explains why alternative options were rejected. This comparative reasoning strategy strengthens the argument for each choice and shows awareness of the full treatment landscape rather than a single-track view.

Structure breakdown

The paper opens with a brief introduction to bipolar disorder and its significance, followed by a detailed patient case presentation. Three decision sections form the core, each following a consistent internal structure: rationale for the chosen option, reasons for rejecting alternatives, expected outcomes, and ethical considerations. The conclusion synthesizes all three decisions and reinforces the overarching ethical theme of culturally competent, patient-centered care. This parallel structure is especially effective for case-based nursing papers.

Introduction to the Case

Bipolar disorder is a chronic illness that has gained increased clinical emphasis over the past few decades. Depressive symptoms are included in this condition, which may first be observed during adolescence or young adulthood and can persist throughout the later years of a patient's life (McCormick et al., 2015). Recurrent episodes of mood pathology are characteristic of bipolar disorder, ranging from relative lows to high-level manic periods, with significant depressive episodes in between. This paper explores the symptoms and condition of a patient with bipolar disorder, three suggested therapeutic and pharmacological decisions, the rationale for selecting those decisions, and the ethical implications of each one.

A 26-year-old woman of Korean descent presented with signs of acute mania after a three-week hospitalization. Her diagnosis was confirmed as bipolar disorder. At her first visit to the practitioner's office, she appeared restless yet displayed a cheerful mood. Observable signs included constant movement in her chair and handling objects on the office table.

Her sleep duration was only five hours per day, as she believed sleep was unnecessary and interfered with enjoying life. The hospital physician found her overall physical health to be within normal limits, with a weight of 100 pounds and a height of 5'5". Prescribed medications were not producing the expected effect, as she tested positive for the CYP2D6*10 allele condition, and she self-reported that she was not taking the Lithium originally prescribed to her.

Her mental status appeared satisfactory; she reported no homicidal or suicidal ideation. Her judgment seemed intact, and she did not appear delusional or paranoid. The patient was alert, though her dress was inappropriate for a clinical visit. Her speech was tangential, and her mood was euthymic.

Decision 1: Reinforcing Lithium Adherence

The first decision is to reinforce the patient's adherence to Lithium as previously prescribed. Lithium is clinically proven and FDA-approved for positive outcomes in bipolar patients, particularly those presenting with significant euthymia, depression, and (hypo-)mania (Volkmann et al., 2020).

The other two available options were not selected for the following reasons: since the patient was not initially taking Lithium at all, recommending an increased dose would be premature. She should first be encouraged to adhere to the original medication plan, so that if effective results are not observed even after consistent use of the prescribed dose, a revised higher dosage could then be considered. It is essential that she understand the importance of medication adherence and its long-term effects on her condition, as poor adherence can worsen functioning and widen the "efficacy-effectiveness" gap while limiting improvements in the disorder (Gaudiano et al., 2008).

After selecting this option, it was anticipated that the patient would demonstrate improved adherence patterns following education about medication adherence and its effects, in conjunction with taking the prescribed dosage (Taibanguay et al., 2019). Additionally, given her CYP2D6*10 allele condition, her metabolism and physiological response to medication may not be suitable for a higher dose. Evidence suggests that bipolar patients with this pharmacogenomic profile may exhibit a revolving-door pattern of hospitalization that is often not adequately addressed due to the high economic costs of re-hospitalization (Seripa et al., 2018).

The ethical consideration of cultural competency in communicating with Asian — specifically Korean — patients is a critical factor in establishing trust with the physician. With entrusted professional activities (EPA), the assessment and implementation of pharmacological treatment would be more effective, as meaningful communication ensures patient-centered care and genuine understanding (Younas et al., 2021). Cultural sensitivity, empathy, and informed knowledge are integral to ethical clinical practice, and principles such as truthfulness and patient confidentiality guide the practitioner toward a more effective therapeutic role (Hoop et al., 2008).

Decision 2: Assessing and Addressing Medication Non-Compliance

The second decision is to assess the rationale behind the patient's non-compliance with her prescribed medication, identify the root cause, and educate her on stopping this behavior through the dissemination of knowledge about drug effects and pharmacology. Research has demonstrated that patients' beliefs play an important role in medication adherence, and for bipolar pharmacological treatment to succeed, poor adherence that contributes to elevated mortality or morbidity rates can be highly detrimental (Tan, 2020). Beliefs about medication may be shaped by sociodemographic factors, pre-held opinions, and personal preferences. In this patient's case, she is displaying primary non-adherence, meaning she has discontinued the medication on her own initiative (Tan, 2020).

The other two options were not selected because increasing the Lithium dose or switching the patient to Risperdal could produce adverse effects on her health. One of those medications might increase her sleep hours but would not be advisable given her current weight. The other might cause excessive lethargy, which could result in her needing assistance to attend future appointments — a marked contrast to her initially cheerful and self-sufficient presentation.

It is anticipated that the patient will adhere to medication with enhanced motivation, as self-efficacy is expected to serve as a mediating factor. A strong relationship has been confirmed between adherence education and higher levels of health information. Self-efficacy, in particular, has been shown to promote patient motivation toward their own well-being (Nafaradi et al., 2017). The same outcome is hoped for in this case.

The relevant ethical consideration involves what may be termed an "ethical nudge" — influencing a patient's decisions by organizing their environment to support better self-care and encourage health behaviors that are beneficial for managing chronic conditions like bipolar disorder (Reach, 2016). While some critics raise concerns that patient education may veer into manipulation of patient beliefs, patient education is fundamentally about the informational and interpretive dissemination of knowledge to an autonomous individual who retains full freedom to accept or reject it (Reach, 2016).

1 locked section · 270 words
Sign up to read the full analysis
Decision 3: Seroquel XR as a Treatment Option270 words
The third decision is the least desirable among the options considered but remains viable due to its potential for better results on the Young Mania Rating Scale and an increased number of sleeping hours. Reduced sleep is associated with bipolar disorder and with aggravation of…
Read the full paper →
Plus 130,000+ examples & all writing tools

Conclusion

The three selected decisions are recommended based on the client's condition regarding bipolar disorder. The client's current physical health appears generally stable, but several clinical issues remain to be addressed, and the prevention of future acute mania episodes is a priority. The first decision involves continuing Lithium as recommended by the former hospital physician, given that Lithium has demonstrated positive health outcomes for bipolar patients as supported by the evidence base. The second decision addresses the assessment of the patient's rationale for medication non-compliance. Primary non-adherence is identified as a key factor contributing to the recurrence of symptoms, as the medications that research has validated for positive outcomes in bipolar disorder are not being taken as prescribed. The third decision, while least desirable overall, was selected for its potential to improve the Young Mania Rating Scale score and increase the patient's sleep duration.

Similar positive outcomes were anticipated across all three decisions, as the overarching goal is to improve health outcomes for this patient. With respect to ethical implications, cultural competency is a mandatory element of clinical practice for nurse practitioners, as effective communication is essential to building trust and fostering patient motivation toward self-adherence and enhanced self-efficacy. Confidentiality, patient education without manipulation, truthfulness, transparency, and honesty in ensuring that patients are fully informed are among the core ethical obligations of the practitioner in this case.

References

Gaudiano, B. A., Weinstock, L. M., & Miller, I. W. (2008). Improving treatment adherence in bipolar disorder: A review of current psychosocial treatment efficacy and recommendations for future treatment development. Behavior Modification, 32(3), 267–301.

Hensch, T., Wozniak, D., Spada, J., Sander, C., Ulke, C., Wittekind, D. A., Thiery, J., Loffler, M., Jawinski, P., & Hegerl, U. (2019). Vulnerability to bipolar disorder is linked to sleep and sleepiness. Translational Psychiatry, 9. https://doi.org/10.1038/s41398-019-0632-1

Hoop, J. G., DiPasquale, T., Hernandez, J. M., & Roberts, L. W. (2008). Ethics and culture in mental health care. Ethics and Behavior, 18(4), 353–372.

McCormick, U., Murray, B., & McNew, B. (2015). Diagnosis and treatment of patients with bipolar disorder: A review for advanced practice nurses. Journal of the American Association of Nurse Practitioners, 27(9), 530–542.

Muneer, A. (2015). Pharmacotherapy of bipolar disorder with quetiapine: A recent literature review and an update. Clinical Psychopharmacology and Neuroscience: The Official Scientific Journal of the Korean College of Neuropsychopharmacology, 13(1), 25–35. https://doi.org/10.9758/cpn.2015.13.1.25

Nafaradi, L., Nakamoto, K., & Schulz, P. J. (2017). Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control, and medication adherence. PLOS ONE, 12(10). https://doi.org/10.1371/journal.pone.0186458

Reach, G. (2016). Patient education, nudge, and manipulation: Defining the ethical conditions of the person-centered model of care. Dove Press, 10. https://www.dovepress.com/patient-education-nudge-and-manipulation-defining-the-ethical-conditio-peer-reviewed-fulltext-article-PPA

Seripa, D., Lozupone, M., Miscio, G., Stella, E., La Montagna, M., Gravina, C., Urbano, M., di Mauro, L., Daniele, A., Greco, A., Logroscino, G., Panza, F., & Bellomo, A. (2018). CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series. Medicine, 97(37), e11998.

Silveira, E. A., Santos, A. S. C., Ribeiro, J. N., Noll, M., Rodrigues, A. P. S., & de Oliveira, C. (2021). Prevalence of constipation in adults with obesity class II and III and associated factors. BMC Gastroenterology, 21. https://doi.org/10.1186/s12876-021-01806-5

Taibanguay, N., Chaiamnuay, S., Asavatanabodee, P., & Narongroeknawin, P. (2019). Effect of patient education on medication adherence of patients with rheumatoid arthritis: A randomized controlled trial. Patient Preference and Adherence, 13, 119–129. https://doi.org/10.2147/PPA.S192008

Tan, C. S. (2020). The need of patient education to improve medication adherence among hypertensive patients. Malaysian Journal of Pharmacy (MJP), 6(1). https://doi.org/10.52494/MOEL1486

Volkmann, C., Bschor, T., & Köhler, S. (2020). Lithium treatment over the lifespan in bipolar disorders. Frontiers in Psychiatry, 11, 377. https://doi.org/10.3389/fpsyt.2020.00377

Younas, A., Khan, R. A., & Yasmin, R. (2021). Entrustment in physician-patient communication: A modified Delphi study using the EPA approach. BMC Medical Education, 21. https://doi.org/10.1186/s12909-021-02931-1

Key Concepts in This Paper
Bipolar Disorder Lithium Therapy Medication Adherence CYP2D6 Allele Acute Mania Cultural Competency Seroquel XR Patient Education Self-Efficacy Ethical Nudge
Cite This Paper
PaperDue. (2026). Bipolar Disorder Therapy: Three Clinical Decisions Explored. PaperDue. https://www.paperdue.com/study-guide/bipolar-disorder-therapy-clinical-decisions-2179473

Always verify citation format against your institution’s current style guide requirements.